Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention
COVID-19 is an infectious disease that affects the respiratory system and is caused by the novel coronavirus SARS-CoV-2. It was first reported in Wuhan, China, on December 31, 2019, and has affected the entire world. This pandemic has caused serious health, economic and social problems. In this situ...
Main Authors: | Asmaa Rhazouani, Khalid Aziz, Halima Gamrani, Lhoucine Gebrati, Md Sahab Uddin, Aziz Faissal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Current Research in Pharmacology and Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590257121000493 |
Similar Items
-
Synthesis and Toxicity of Graphene Oxide Nanoparticles: A Literature Review of In Vitro and In Vivo Studies
by: Asmaa Rhazouani, et al.
Published: (2021-01-01) -
COVID-19 therapy: from myths to reality and hopes
by: S. V. Bozrova, et al.
Published: (2020-12-01) -
Antivirals for COVID-19: A critical review
by: Andri Frediansyah, et al.
Published: (2021-01-01) -
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
by: Irina Leneva, et al.
Published: (2021-08-01) -
The dual sides of interferon induction in COVID-19 treatment
by: Sadra Nadimi Parashkouhi, et al.
Published: (2021-03-01)